SIGMOVIR BIOSYSTEMS, INC.
Virus-like particle (VLP) vaccine against respiratory syncytial virus (RSV) for maternal immunization to protect neonates
- Sector
- Biotech
- Headquarters
- Rockville, MD
- Total capital
- $13.7M
- Federal grants
- $8.9M
- 10 awards · 2016–2024
- Rank in peer group#63 of 514
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $4.9M
- 5 awards · Health and Human S
- Rank in Biotech#82 of 4373
- Granted patents
- 3
- 1 pending · first 2015
- Rank in peer group#109 of 514
Capital timeline
Latest events
- Federal contractHealth and Human S · Reagents For Immunologic Analysis Of Cotton Rat.$599K
- Federal contractHealth and Human S · Collection Of Metadata From In Vivo Studies Performed Under Previous Idiq Contract Mechanisms$80K
- Federal grantHealth and Human S · Phase I · Inducible HMGB1 antagonist for viral-induced acute lung injury.$63K
- Federal grantHealth and Human S · Phase I · Inducible HMGB1 antagonist for viral-induced acute lung injury.$488K
- Federal grantHealth and Human S · Phase I · Inducible HMGB1 antagonist for viral-induced acute lung injury.$30K
- Federal contractHealth and Human S · Pre-clinical Models Of Infectious Diseases$1.5M
- Federal grantHealth and Human S · Phase I · Inducible HMGB1 antagonist for viral-induced acute lung injury.$488K
Show 8 earlier federal awards
- Federal grantHealth and Human S · Phase II · Development of VLP vaccine for RSV$1M
- Federal contractHealth and Human S · Cotton Rat Model For The Evaluation Of Vaccines And Therapeutics For Rsv And Related Viruses For Sigmovir Biosystems, Inc$1.7M
- Federal grantHealth and Human S · Phase II · Development of VLP vaccine for RSV$477K
- Federal grantHealth and Human S · Phase II · Development of VLP vaccine for RSV$1M
- Federal grantHealth and Human S · Phase II · Development of VLP vaccine for RSV$3.5M
- Federal contractHealth and Human S · Base Task Order Funding; To A15 Award; 1700028I Sigmovir Biosystems, INC.;RDB--10; Iid Can 8470036 $591,222$950K
- Federal grantHealth and Human S · Phase II · Development of VLP vaccine for RSV$934K
- Federal grantHealth and Human S · Phase II · Development of VLP vaccine for RSV$934K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 514 peers
Line = medianBiotech · Molecule
- Federal grants#63 · top 12%
- Granted patents#109 · top 21%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 3 granted of 4- GrantedHerpes Simplex Virus Vaccine Compositions and Methods of Production and Use ThereofUSPTOUS 9,919,045
- GrantedVaccination by Circumventing Preexistent ImmunityUSPTOUS 9,149,508
- GrantedProtection Against Human Rhinovirus InfectionUSPTOUS 9,121,048
Show all 4 patent records
- Herpes Simplex Virus Vaccine Compositions and Methods of Production and Use ThereofMar 20, 2018 · US 9,919,045Granted
- Vaccination by Circumventing Preexistent ImmunityOct 6, 2015 · US 9,149,508Granted
- Protection Against Human Rhinovirus InfectionSep 1, 2015 · US 9,121,048Granted
- Herpes Simplex Virus Vaccine Compositions and Methods of Production ThereofApplication 62196564Pending
Related companies, and why
- PLATELET BIOGENESIS, INCSimilar federal contract value in Biotech · $5M in contracts
- AUTONOMOUS THERAPEUTICS INCSimilar federal contract value in Biotech · $4.9M in contracts
- QRONO, INCSimilar federal contract value in Biotech · $4.9M in contracts
- MIMEDX GROUP, INC.Similar federal contract value in Biotech · $4.8M in contracts
- METACLIPSE THERAPEUTICS CORPSimilar federal contract value in Biotech · $4.7M in contracts
- Biomedical Research Models, Inc.Similar federal contract value in Biotech · $4.6M in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .